Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-14

Clinical Trial Update: The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of an NAD+ boosting product combined with a low-carbohydrate diet in adults with mild hypertension; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAD+ boosting product

Snippet

Sponsor: Limitless Research Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED